NEVRO CORP (NVRO) Fundamental Analysis & Valuation

NYSE:NVRO • US64157F1030

Current stock price

5.84 USD
0 (0%)
At close:
5.8401 USD
0 (0%)
After Hours:

This NVRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NVRO Profitability Analysis

1.1 Basic Checks

  • NVRO had negative earnings in the past year.
  • NVRO had a negative operating cash flow in the past year.
  • In the past 5 years NVRO reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: NVRO reported negative operating cash flow in multiple years.
NVRO Yearly Net Income VS EBIT VS OCF VS FCFNVRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • NVRO has a Return On Assets (-20.48%) which is comparable to the rest of the industry.
  • NVRO has a Return On Equity of -49.11%. This is comparable to the rest of the industry: NVRO outperforms 48.17% of its industry peers.
Industry RankSector Rank
ROA -20.48%
ROE -49.11%
ROIC N/A
ROA(3y)-11.5%
ROA(5y)-13.58%
ROE(3y)-26.55%
ROE(5y)-28.86%
ROIC(3y)N/A
ROIC(5y)N/A
NVRO Yearly ROA, ROE, ROICNVRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

  • The Gross Margin of NVRO (65.98%) is better than 68.06% of its industry peers.
  • NVRO's Gross Margin has been stable in the last couple of years.
  • NVRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.17%
GM growth 5Y-0.71%
NVRO Yearly Profit, Operating, Gross MarginsNVRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NVRO Health Analysis

2.1 Basic Checks

  • NVRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NVRO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NVRO has more shares outstanding
  • NVRO has a worse debt/assets ratio than last year.
NVRO Yearly Shares OutstandingNVRO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NVRO Yearly Total Debt VS Total AssetsNVRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • NVRO has an Altman-Z score of -0.62. This is a bad value and indicates that NVRO is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NVRO (-0.62) is comparable to the rest of the industry.
  • NVRO has a Debt/Equity ratio of 0.98. This is a neutral value indicating NVRO is somewhat dependend on debt financing.
  • NVRO has a Debt to Equity ratio of 0.98. This is in the lower half of the industry: NVRO underperforms 73.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACC8.29%
NVRO Yearly LT Debt VS Equity VS FCFNVRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.62 indicates that NVRO has no problem at all paying its short term obligations.
  • The Current ratio of NVRO (4.62) is better than 73.82% of its industry peers.
  • NVRO has a Quick Ratio of 3.62. This indicates that NVRO is financially healthy and has no problem in meeting its short term obligations.
  • NVRO has a better Quick ratio (3.62) than 70.68% of its industry peers.
Industry RankSector Rank
Current Ratio 4.62
Quick Ratio 3.62
NVRO Yearly Current Assets VS Current LiabilitesNVRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NVRO Growth Analysis

3.1 Past

  • NVRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.29%, which is quite impressive.
  • NVRO shows a decrease in Revenue. In the last year, the revenue decreased by -3.92%.
  • The Revenue has been growing slightly by 0.92% on average over the past years.
EPS 1Y (TTM)25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y1.83%
Revenue growth 5Y0.92%
Sales Q2Q%-9.15%

3.2 Future

  • NVRO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.68% yearly.
  • Based on estimates for the next years, NVRO will show a small growth in Revenue. The Revenue will grow by 4.43% on average per year.
EPS Next Y-29.92%
EPS Next 2Y-6.37%
EPS Next 3Y-1.23%
EPS Next 5Y7.68%
Revenue Next Year0.32%
Revenue Next 2Y2.33%
Revenue Next 3Y3.23%
Revenue Next 5Y4.43%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVRO Yearly Revenue VS EstimatesNVRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
NVRO Yearly EPS VS EstimatesNVRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. NVRO Valuation Analysis

4.1 Price/Earnings Ratio

  • NVRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NVRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVRO Price Earnings VS Forward Price EarningsNVRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVRO Per share dataNVRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.37%
EPS Next 3Y-1.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NVRO Dividend Analysis

5.1 Amount

  • NVRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NVRO Fundamentals: All Metrics, Ratios and Statistics

NEVRO CORP

NYSE:NVRO (4/2/2025, 8:04:00 PM)

After market: 5.8401 0 (0%)

5.84

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners99.47%
Inst Owner Change0%
Ins Owners2.02%
Ins Owner Change0%
Market Cap221.22M
Revenue(TTM)408.52M
Net Income(TTM)-113.44M
Analysts53.68
Price Target8.87 (51.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.9%
Min EPS beat(2)49.33%
Max EPS beat(2)50.46%
EPS beat(4)4
Avg EPS beat(4)42.48%
Min EPS beat(4)24.11%
Max EPS beat(4)50.46%
EPS beat(8)8
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)217.02%
EPS beat(16)15
Avg EPS beat(16)164.13%
Revenue beat(2)2
Avg Revenue beat(2)1.5%
Min Revenue beat(2)0.92%
Max Revenue beat(2)2.09%
Revenue beat(4)3
Avg Revenue beat(4)0.05%
Min Revenue beat(4)-4.87%
Max Revenue beat(4)2.09%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)5
Avg Revenue beat(12)0.11%
Revenue beat(16)7
Avg Revenue beat(16)0.05%
PT rev (1m)0%
PT rev (3m)10.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.89%
EPS NY rev (1m)0.24%
EPS NY rev (3m)1.14%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-1.92
EYN/A
EPS(NY)-2.49
Fwd EYN/A
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS10.78
BVpS6.1
TBVpS5.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.48%
ROE -49.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.98%
FCFM N/A
ROA(3y)-11.5%
ROA(5y)-13.58%
ROE(3y)-26.55%
ROE(5y)-28.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.17%
GM growth 5Y-0.71%
F-Score2
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.79%
Cap/Sales 2.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.62
Quick Ratio 3.62
Altman-Z -0.62
F-Score2
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)111.23%
Cap/Depr(5y)142.49%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-29.92%
EPS Next 2Y-6.37%
EPS Next 3Y-1.23%
EPS Next 5Y7.68%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y1.83%
Revenue growth 5Y0.92%
Sales Q2Q%-9.15%
Revenue Next Year0.32%
Revenue Next 2Y2.33%
Revenue Next 3Y3.23%
Revenue Next 5Y4.43%
EBIT growth 1Y11.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.02%
EBIT Next 3Y28.25%
EBIT Next 5Y19.53%
FCF growth 1Y56.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.96%
OCF growth 3YN/A
OCF growth 5YN/A

NEVRO CORP / NVRO Fundamental Analysis FAQ

What is the fundamental rating for NVRO stock?

ChartMill assigns a fundamental rating of 2 / 10 to NVRO.


What is the valuation status for NVRO stock?

ChartMill assigns a valuation rating of 0 / 10 to NEVRO CORP (NVRO). This can be considered as Overvalued.


Can you provide the profitability details for NEVRO CORP?

NEVRO CORP (NVRO) has a profitability rating of 2 / 10.


What is the expected EPS growth for NEVRO CORP (NVRO) stock?

The Earnings per Share (EPS) of NEVRO CORP (NVRO) is expected to decline by -29.92% in the next year.